Jaguar Health, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| JAGX | 18H0.F | NIKI | TRAW | TOVX | IBO | |
|---|---|---|---|---|---|---|
| Market cap | 1.16M | 5.11M | 5.27M | 4.13M | 8.72M | 35.42M |
| P/E (TTM) | — | — | — | — | 0.3 | 0.4 |
| Forward P/E | -0.1 | — | — | -0.1 | -1.0 | — |
| Price/book | 0.0 | -1.1 | 0.1 | 2.4 | 0.7 | 3.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −99.94% | −25.00% | −87.62% | −86.70% | −29.63% | −39.34% |
| Today | −10.53% | −23.81% | −3.98% | −11.06% | +4.40% | +1.99% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All JAGX news ›Jaguar Health Converts Series R Preferred Shares Into Common Stock
TradingView Jaguar Health Converts Series R Preferred Shares Into Common Stock Jaguar Health completed the conversion of its Series R preferred stock into common shares, bringing issued and outstanding common stock to 13,345,986 sha
Critical Review: Ocular Therapeutix (NASDAQ:OCUL) versus Jaguar Animal Health (NASDAQ:JAGX)
Posted by Kim Johansen on Oct 27th, 2026 Jaguar Animal Health (NASDAQ:JAGX – Get Free Report) and Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will…
JAC Recruitment Co., Ltd. Announces Dividend for the Second Quarter-End of the Fiscal Year Ending 31 December 2026, Payable on 28 September 2026
JAC Recruitment Co., Ltd. announced dividend for the second quarter-end of the fiscal year ending 31 December 2026. For the period, the company announced dividend of JPY 19.00 per share. Scheduled... JAC Recruitment Co., Ltd. JAC…
Jaguar Health's Crofelemer Shows Benefit for Intestinal Failure (IF) in Third Rare Congenital Enteropathy Disorder
Mutation of the GUCY2C gene is the third IF-related congenital enteropathy, in addition to microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF), for which crofelemer
JD Bancshares, Inc. Declares Cash Dividend
Soluna Agrees to Form Strategic Partnership with Applied Digital to Develop Wind-Powered AI Data Center in Texas VivoPower Signs Definitive Heads of Agreement with Open Innovation AI to Develop Secure Sovereign AI Data Centers Across the…
Jaguar Health Provides Update Regarding Special Stock Dividend
The Tennessean Jaguar Health Provides Update Regarding Special Stock Dividend Dividend intended to provide dilution protection to Jaguar shareholders as company continues evaluation of strategic alternatives Jaguar’s rare disease intes
More from 1 other outlet
Positive Preliminary Results Presented at Annual American College of Gastroenterology Meeting for Open-Label Study in Adult Short Bowel Syndrome Patients with Intestinal Failure (SBS-IF) with Jaguar Health's Crofelemer
Company remains sharply focused on its ongoing rare disease intestinal failure g
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Intestinal Failure Panel Discussion at Pediatric Gastroenterology Conference in Abu Dhabi
Company remains sharply focused on its ongoing rare disease intestinal failure global development program for microvillus inclusion disease (MVID) and short bowel syndrome (SBS) for crofelemer powder for oral solution, targeting an NDA…
Jaguar Health (JAGX) Stock Climbs Over 34% After-Hours: What's Going On?
Jaguar Health Inc. JJAGX shares soared 34.67% to $6.37 in after-hours trading on Monday. In the regular session, JAGX closed at $4.73, up 29.23%, according to Benzinga Pro data. On Monday, the stock of the California-based commercial-stage…
Jaguar Health Defers Royalty Payments, Extends $6.22M Note, and Gains Series P Consent
Agreement 1: Jaguar Health Defers Uptown Royalty Payments to 2027, Sets $750,000 Monthly Minimum Agreement 2: Jaguar Health Defers Streeterville Royalty Payments to 2027, Sets $750,000 Monthly Minimum Agreement 3: Jaguar Health Extends…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- stocktitan.net4
- tradingview.com3
- marketscreener.com2
- accessnewswire.com1
- biospace.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 13 articles, not a forecast.